reSET® 1
by Pear Therapeutics, Inc. 2 variants
reSET 1 is a psychological assessment software (FDA Class II; FDA product code PWE, Computerized Behavioral Therapy Device For Psychiatric Disorders) made by Pear Therapeutics, Inc., granted FDA De Novo DEN160018 on 14 Sep 2017 and listed in FDA GUDID since 8 Jun 2022 (UDI-DI 10196439000005), active as of 23 Oct 2026.
Active
De Novo
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number10196439000005 | Date8 Jun 2022 | StatusListed |
| United States | FDA De NovoDENG | NumberDEN160018 | Date14 Sep 2017 | StatusActive |
Official records
- AccessGUDID record 10196439000005
- FDA De Novo database DEN160018
From the FDA record
- Device description
- reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 days) prescriptiononly treatment for patients with Substance Use Disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: increase abstinence from a patient’s substances of abuse during treatment, and increase retention in the outpatient treatment program. This configuration of reSET is intended to provide virtual incentives as well as monetary incentives to the patients based on the Contingency management system.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA De Novo DEN160018 decided 14 Sep 2017 Active
- FDA GUDID UDI-DI 10196439000005 listed 8 Jun 2022 Listed
Timeline
- Granted FDA De Novo DEN160018
- Listed FDA GUDID 10196439000005
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA De Novo Active
Specification
- Trade name
- reSET®
- Generic name
- Psychological assessment software
- Model / Ref / Catalog
- 1
- Primary DI / UDI-DI
- 10196439000005
- De Novo Number
- FDA product code
- PWE
- GMDN term
- Psychological assessment software
- Device class
- Class II
- Regulation number
- 882.5801
- GUDID distribution status
- In Commercial Distribution